NIHR Oxford Health Biomedical Research Centre (OH BRC) and NIHR Oxford Biomedical Research Centre (OBRC) are seeking committed individuals to join their Diversity in Research Group to share experiences and ideas related to health.

Triptans, a drug usually offered as an alternative to painkillers, have been found to be the most effective medicine for adults who experience acute migraines. Findings of a study, which … Read more

The September issue of the OH BRC Newsletter is now available to read on the OH BRC website.

Research staff at Oxford Health recently attended the Autumn Information Fayre at the Windmill Centre in Deddington to provide information opportunities to take part in dementia research.

Professor Sir Jonathan Montgomery has been appointed as the new chair of the Board of the Oxford Academic Health Partners (OAHP).

Around nine in ten research participants in the Thames Valley area said that they would take part in another study in the future.

The impact of concussion while playing sport is different in those who don’t play professionally, according to new research.

Participants are being recruited for the Social Cognition and Functioning in Alzheimer’s Dementia (SOCIAL) study at Oxford Health NHS Foundation Trust.

Dr Anya Topiwala, consultant psychiatrist at the Trust and Wellcome Clinical Career Development Fellow at the University of Oxford’s Big Data Institute, has been awarded a £2.4 million Wellcome Career Development Award to grow her research team.

This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of Alzheimer’s disease.